Perspective on the current use of bortezomib in multiple myeloma

Haematologica. 2006 Jul;91(7):871-2.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Boronic Acids / therapeutic use*
  • Boronic Acids / toxicity
  • Bortezomib
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Humans
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy*
  • Protease Inhibitors / therapeutic use
  • Pyrazines / therapeutic use*
  • Pyrazines / toxicity

Substances

  • Boronic Acids
  • Protease Inhibitors
  • Pyrazines
  • Bortezomib